The Foreign Corrupt Practices Act: Risk-Management and Compliance Strategies For High-Tech Companies
16 October 2009
Just past its 30th birthday, the Foreign Corrupt Practices Act of 1977 (the FCPA or the Act) today poses the greatest liability risks ever for U.S. firms and other covered entities pursuing business opportunities abroad. Chiefly, this risk arises due to the increased risk of prosecution by the U.S. government, the government’s increased appetite for large fines, and an increased risk of multiple prosecutions due to other countries having adopted FCPA-equivalent laws.
These changes are ones of emphasis and enforcement rather than a wholesale change in how the FCPA operates. The Act has changed little in its basic parameters over the years. Congress unanimously passed the statute in 1977 following an SEC report disclosing that more than 400 U.S. companies, including 117 of the Fortune 500 companies, made “questionable payments” to foreign officials. The FCPA, as enacted, criminalized the making of “corrupt” payments to foreign government and political officials and adopted rigorous recordkeeping requirements for public companies and their overseas subsidiaries.
Author(s)
Related Insights
11 December 2024
Foley Ignite
A New Era for the FTC
As 2024 comes to a close, so does the current leadership of the FTC.
11 December 2024
Health Care Law Today
Antibody Drug Conjugates Keep Growing: What You Need to Know
Since 2018, licensing deals totaling over $60 billion have been signed regarding Antibody Drug Conjugates (ADCs), with 2023 alone having at least 18 deals.
10 December 2024
Health Care Law Today
Massachusetts “Patients First Act” Implementation and Enforcement Re-Extended
The Massachusetts Senate proposed an amendment on Monday December 2, 2024, that would delay implementation and enforcement of the 2021 Patients First Act addressing health care cost transparency.